A carregar...
Population pharmacokinetics of tofacitinib in patients with psoriatic arthritis
Objective: Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This analysis characterized the pharmacokinetics (PK) of tofacitinib in adult patients with active PsA and evaluated the impact of covariates (baseline characteristics) on the disposition of tofa...
Na minha lista:
| Publicado no: | Int J Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dustri-Verlag Dr. Karl Feistle
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6704728/ https://ncbi.nlm.nih.gov/pubmed/31319908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP203516 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|